INDIRECT 24-HR BLOOD-PRESSURE MONITORING IN THE ASSESSMENT OF THE ANTIHYPERTENSIVE EFFICACY OF A FIXED COMBINATION OF 160 MG VERAPAMIL, 50 MG TRIAMTERENE AND 25 MG HYDROCHLOROTHIAZIDE

被引：0

|

作者：

LANGEWITZ, W

BAHR, M

RUDDEL, H

SCHACHINGER, H

机构：

来源：

HERZ KREISLAUF | 1989年 / 21卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

收藏

页码：269 / 272

页数：4

相关论文

共 46 条

[1] ANTIHYPERTENSIVE EFFECT OF THE CAPTOPRIL (50 MG) AND HYDROCHLOROTHIAZIDE (25 MG) COMBINATION EVALUATED BY AMBULATORY BLOOD-PRESSURE RECORDING
ASMAR, R
BOULANGER, P
BENETOS, A
DARNE, B
LAURENT, S
SAFAR, M
PRESSE MEDICALE, 1991, 20 (26): : 1215 - 1218
[2] A comparison of the antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination with captopril 50 mg/hydrochlorothiazide 25 mg fixed combination
Milon, H
Baleydier, A
THERAPIE, 1997, 52 (03): : 195 - 205
[3] Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients
A de la Sierra
B Gil-Extremera
C Calvo
C Campo
J García-Puig
E Márquez
J Oliván
A Roca Cusachs
S Sanz de Castro
C Pontes
J Delgadillo
Journal of Human Hypertension, 2004, 18 : 215 - 222
[4] Efficacy and safety of valsartan 160mg/hydrochlorothiazide 25mg combination in patients with hypertension not adequately controlled by valsartan 160mg/hydrochlorothiazide 12.5mg
Trenkwalder, P
Ulmer, HJ
Weidinger, G
Handrock, R
CLINICAL DRUG INVESTIGATION, 2004, 24 (10) : 593 - 602
[5] Efficacy and Safety of Valsartan 160mg/Hydrochlorothiazide 25mg Combination in Patients with Hypertension not Adequately Controlled by Valsartan 160mg/ Hydrochlorothiazide 12.5mg
Peter Trenkwalder
Hans-Joachim Ulmer
Gottfried Weidinger
Renate Handrock
Clinical Drug Investigation, 2004, 24 : 593 - 602
[6] Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients
de la Sierra, A
Gil-Extremera, B
Calvo, C
Campo, C
García-Puig, J
Márquez, E
Oliván, J
Cusachs, AR
de Castro, SS
Pontes, C
Delgadillo, J
JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (03) : 215 - 222
[7] Evaluation by ambulatory blood pressure measurement of the antihypertensive effect of the fixed combination therapy valsartan 80 mg and hydrochlorothiazide 12.5 mg
Vaisse, B
Ghobrial, H
Vaur, L
Poncelet, P
Asmar, R
Herpin, D
Mallion, JM
JOURNAL OF HYPERTENSION, 2001, 19 (08) : A2 - A2
[8] Effect of the fixed combination of irbesartan 300 mg/hydrochlorothiazide 25 mg on the circadian blood pressure profile in essential hypertension
Coca, A
Calvo, C
Sabrino, J
Sierra, C
López-Paz, JE
Gómez-Angelats, E
Bragulat, E
de la Sierra, A
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 189A - 189A
[9] COMPARISON OF BENAZEPRIL 10-MG AND THE FIXED COMBINATION BENAZEPRIL 5-MG HYDROCHLOROTHIAZIDE 6.25-MG ON EXERCISE BLOOD-PRESSURE
BOUTELANT, S
FRANCILLON, A
SICHE, JP
COCCOGUYOMARCH, L
MALLION, JM
THERAPIE, 1995, 50 (04): : 313 - 318
[10] EVALUATION BY 24-HOUR AMBULATORY BLOOD-PRESSURE MONITORING OF EFFICACY OF BENAZEPRIL 20-MG PLUS HYDROCHLOROTHIAZIDE 25-MG FIXED COMBINATION AS COMPARED TO CAPTOPRIL 25-MG PLUS HYDROCHLOROTHIAZIDE 25-MG FIXED COMBINATION IN TREATING MILD-TO-MODERATE HYPERTENSION - A DOUBLE-BLIND, WITHIN-PATIENT, PLACEBO-CONTROLLED STUDY
FOGARI, R
ZOPPI, A
TETTAMANTI, F
TETTAMANZI, D
LUSARDI, P
MOTOLESE, M
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (05) : 687 - 693

← 1 2 3 4 5 →